The effect of anaesthetic technique on postoperative nausea and vomiting after day-case gynaecological laparoscopy.
Gynaecological surgery is of high emetogenic potential and both total intravenous anaesthesia (TIVA) and prophylactic antiemetic therapy may reduce the incidence of postoperative nausea and vomiting (PONV). We studied 144 patients scheduled for day-case gynaecological laparoscopy in a randomized trial comparing balanced inhalational anaesthesia and prophylactic dolasetron (group I+D) with propofol TIVA and dolasetron (group T+D) or TIVA alone (group T). The primary outcome of "complete response" (no vomiting, no treatment for PONV) was not significantly different among groups (34%, 51%, 32%; groups I+D vs T+D vs T, P=0.12). During the first hour after surgery, group I+D had nausea of greater severity (P<0.03). During hospital admission, group T had more vomiting (P<0.03). From discharge until 24 hours postoperatively, 55% of group I+D experience nausea and 38% vomited. The incidence and severity of nausea were significantly lower in the TIVA groups (P<0.04 and <0.05 respectively). There were no significant differences between groups T+D and T, although comparing all groups the complete response rate was highest and the post-discharge incidence and severity of nausea lowest in group T+D. In conclusion, propofol TIVA, with or without dolasetron, reduced postoperative nausea, but not perioperative vomiting or antiemetic requirement, when compared with inhalational anaesthesia plus dolasetron.
Paech
M J
MJ
Department of Anaesthesia, King Edward Memorial Hospital for Women, Perth, Western Australia.
Lee
B H S
BH
Evans
S F
SF
D000328:Adult; D000556:Ambulatory Surgical Procedures; D000769:Anesthesia, Inhalation; D000771:Anesthesia, Intravenous; D018686:Anesthetics, Intravenous; D000932:Antiemetics / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D007211:Indoles / Q000008:administration & dosage*; D010535:Laparoscopy; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D011292:Premedication; D015742:Propofol; D011446:Prospective Studies; D011807:Quinolizines / Q000008:administration & dosage*
D018686:Anesthetics, Intravenous; D000932:Antiemetics; D007211:Indoles; D011807:Quinolizines; C060344:dolasetron; D015742:Propofol